Glooko announced today that it appointed Dr. David Pass as president of life sciences and Adam Hameed as president of connected care.
Palo Alto, California-based Glooko established the new roles to position itself for continued growth and innovation in chronic condition management. It wants to drive advances in life sciences, specifically digital companions/therapeutics, clinical research, real-world data and device integrations.
Glooko’s current platforms enable patients to share diabetes data with healthcare providers. That includes blood glucose readings, insulin doses, food and carbs, exercise activity, blood pressure and weight. The company’s recent endeavors include digital therapeutics and insulin delivery partnerships.
Pass joins Glooko with more than 25 years of commercial and business leadership. He previously served as COO and CCO at Gelesis and as VP of marketing at Boehringer Ingelheim for diabetes. His experience in chronic conditions should further accelerate Glooko’s growth in life sciences.
Hameed served as chief growth officer at Andros and as chief development officer at Cricket Health. He also held key leadership positions at Optum, leading payer sales and account management efforts. Glooko says Hameed assumes a pivotal role in advancing the connected care growth strategy. His focus centers around global sales and account management.
“We are thrilled to welcome David and Adam as presidents of life sciences and connected care,” said Russ Johannesson, CEO of Glooko. “With David and Adam leading our market facing strategies for these differentiated business units, we are confident that their unique experience and close collaboration will help Glooko drive significant new value for our customers, users and partners globally.”
